Results 81 to 90 of about 6,378 (227)

Analysis of the accuracy of Z-scores of non-invasive prenatal testing for fetal Trisomies 13, 18, and 21 that employs the ion proton semiconductor sequencing platform

Molecular Cytogenetics, 2018
Background Non-invasive prenatal testing (NIPT) is frequently being used to screen for trisomies 13, 18 and 21 for prenatal diagnosis. However, NIPT performs poorly when compared with invasive testing and thus should not be used to diagnose trisomies ...
Yuan Tian, Linlin Zhang, Weifang Tian, Jinshuang Gao, Liting Jia, Shihong Cui   +5 more
doaj   +1 more source

Free Fetal DNA Testing to Guide Early Intervention in the Management of the Kell Alloimmunized Pregnancy

Prenatal Diagnosis, EarlyView.
Kenneth J. Moise Jr, Thomas Trevett, Stephanie Moench, Erin Moise   +3 more
wiley   +1 more source

Rational design of Ni‐based catalysts for methane dry reforming: Recent advances and future perspectives

FlexMat, Volume 3, Issue 3, Page 428-451, September 2026.
Addressing the challenges inherent in dry reforming of methane (DRM), this paper focuses on the structural design and performance optimization of Ni‐based catalysts. The modulation strategies for DRM are systematically reviewed across four dimensions: the micromorphology of active metals, metal‐support interactions, electronic modifications by ...
Bowei Cao, Junlei Zhang, Wanglei Wang
wiley   +1 more source

Finding out the “gender” sooner: Ethical tensions and parental motivation in discovering fetal sex and chromosomal anomaly risk using noninvasive prenatal testing (NIPT)

SSM: Qualitative Research in Health
Noninvasive prenatal testing (NIPT) has rapidly expanded in both utilization and scope since it became available in 2011. While NIPT screens for a limited number of chromosomal anomalies, it has become colloquially known as the “gender” test because of ...
Aleksa Owen, G. Allen Ratliff
doaj   +1 more source

Novel and High‐Throughput Method of Isolating Single Fetal Cells Using FACS for NIPT

Prenatal Diagnosis, Volume 46, Issue 10, Page 1536-1542, September 2026.
ABSTRACT Objective To evaluate fluorescence activated cell sorting (FACS) as a method of single‐cell isolation of rare circulating fetal cells from maternal blood for use in cell‐based non‐invasive prenatal testing (cbNIPT). Method Blood samples (30 mL) were collected from 75 ‘low‐risk’ pregnant women (gestational age 10–15 weeks).
Ripudaman Singh, Bolette Hestbek Nicolaisen, Mathias Kølvraa, Inga Baasch Christensen, Mads Tang Dalsgaard, Lars Henning Pedersen, Niels Uldbjerg, Ida Vogel, Lotte Hatt, Katarina Ravn   +9 more
wiley   +1 more source

NIPT-ohjaus perheen päätöksenteon tukena [PDF]

, 2020
NIPT-potilasohjaukseen vaikuttaa niin odottajasta kuin ohjaajasta lähtevät tekijät sekä ulkopuoliset, resursseihin liittyvät tekijät. Odottajan tausta, asenteet ja raskausviikot vaikuttavat siihen, kuinka positiivisena asiana odottaja näkee NIPT ...
Remes, Saana, Nyman, Anni, Suomalainen, Merja, Manninen, Minna, Kajula, Outi   +4 more
core  

KUB till NIPT vid screening för trisomi 21

, 2020
Bakgrund Fosterdiagnostik har länge varit etiskt diskuterat, inte minst med den snabba utvecklingen avNIPT(non-invasive prenatal testing) som har skett sedan 2011.
Andersson, Hanna
core   +2 more sources

Parental Decision‐Making and Pregnancy Outcomes After Increased First‐Trimester Nuchal Translucency: A 12‐Year Cohort

Prenatal Diagnosis, Volume 46, Issue 10, Page 1520-1528, September 2026.
ABSTRACT Objective To describe diagnostic trajectories and parental decision‐making following increased first‐trimester nuchal translucency (NT), according to NT thickness. Method This 12‐year retrospective cohort study was conducted at a French tertiary Prenatal Diagnosis and Fetal Medicine Center and included 316 singleton pregnancies with first ...
Benjamin Birene, Jean‐Paul Bory, Eloi Dondeyne, Anne Charbonneau, Clémence Jacquin, Emilie Landais, Mohamed Dakin, Olivier Graesslin   +7 more
wiley   +1 more source

Regulating non-invasive prenatal testing (NIPT) for fetal sex determination

, 2023
Non-invasive prenatal testing (NIPT) can be used to determine the chromosomal sex of the fetus at an early stage in a pregnancy. The use of NIPT for fetal sex determination raises concerns about potential selective termination of pregnancy by prospective
Taylor-Sands, M, Bowman-Smart, H, Warton, C   +2 more
core   +1 more source

Model-based analysis of costs and outcomes of non-invasive prenatal testing for Down's syndrome using cell free fetal DNA in the UK National Health Service.

PLoS ONE, 2014
BackgroundNon-invasive prenatal testing (NIPT) for Down's syndrome (DS) using cell free fetal DNA in maternal blood has the potential to dramatically alter the way prenatal screening and diagnosis is delivered. Before NIPT can be implemented into routine
Stephen Morris, Saffron Karlsen, Nancy Chung, Melissa Hill, Lyn S Chitty   +4 more
doaj   +1 more source